Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. | KMTS | $27.31 | $1.63B | — | |
| Sonida Senior Living, Inc. | SNDA | $33.47 | $1.61B | — | |
| Hemab Therapeutics Holdings, Inc. | COAG | $35.34 | $1.60B | — | |
| Phibro Animal Health Corporation | PAHC | $39.25 | $1.59B | 16.2 | 1.24% |
| uniQure N.V. | QURE | $22.69 | $1.57B | — | |
| Ultragenyx Pharmaceutical Inc. | RARE | $15.92 | $1.57B | — | |
| Structure Therapeutics Inc. | GPCR | $22.01 | $1.57B | — | |
| Azenta, Inc. | AZTA | $36.76 | $1.57B | — | |
| COMPASS Pathways plc | CMPS | $11.84 | $1.56B | — | |
| First Tracks Biotherapeutics, Inc. | TRAX | $42.77 | $1.53B | — | |
| agilon health, inc. | AGL | $90.99 | $1.53B | — | |
| Ascentage Pharma Group Internat | AAPG | $16.34 | $1.53B | — | |
| Innoviva, Inc. | INVA | $20.91 | $1.51B | 4.9 | — |
| Freenome, Inc. | FRNM | $14.01 | $1.51B | — | |
| Healthcare Services Group, Inc. | HCSG | $21.71 | $1.49B | 12.7 | — |
| Korsana Biosciences, Inc. | KRSA | $32.54 | $1.48B | — | |
| Certara, Inc. | CERT | $10.18 | $1.46B | — | |
| Pacira BioSciences, Inc. | PCRX | $36.33 | $1.45B | 103.8 | — |
| Inhibrx Biosciences, Inc. | INBX | $98.19 | $1.45B | — | |
| ORIC Pharmaceuticals, Inc. | ORIC | $13.85 | $1.44B | — | |
| The Pennant Group, Inc. | PNTG | $41.04 | $1.43B | 45.1 | — |
| AnaptysBio, Inc. | ANAB | $47.94 | $1.43B | — | |
| CONMED Corporation | CNMD | $47.11 | $1.43B | 25.7 | — |
| Ocular Therapeutix, Inc. | OCUL | $6.48 | $1.42B | — | |
| Tyra Biosciences, Inc. | TYRA | $20.60 | $1.42B | — | |
| Eton Pharmaceuticals, Inc. | ETON | $49.30 | $1.41B | 123.3 | — |
| Nutex Health Inc. | NUTX | $197.61 | $1.35B | 7.8 | — |
| Taysha Gene Therapies, Inc. | TSHA | $4.12 | $1.34B | — | |
| Damora Therapeutics, Inc. | DMRA | $21.53 | $1.33B | — | |
| Nanobiotix S.A. | NBTX | $25.83 | $1.32B | — | |
| Nektar Therapeutics | NKTR | $38.27 | $1.31B | — | |
| GH Research PLC | GHRS | $18.91 | $1.30B | — | |
| U.S. Physical Therapy, Inc. | USPH | $86.28 | $1.29B | 479.3 | 2.11% |
| LB Pharmaceuticals Inc | LBRX | $39.23 | $1.27B | — | — |
| Cronos Group Inc. | CRON | $3.39 | $1.25B | 17.8 | — |
| InnovAge Holding Corp. | INNV | $9.14 | $1.25B | — | |
| Alpha Tau Medical Ltd. | DRTS | $13.48 | $1.25B | — | |
| Silence Therapeutics plc | SLN | $19.67 | $1.22B | — | |
| GoodRx Holdings, Inc. | GDRX | $3.57 | $1.22B | 71.4 | — |
| Bicara Therapeutics Inc. | BCAX | $17.91 | $1.21B | — | |
| Omada Health, Inc. | OMDA | $19.66 | $1.20B | 81.9 | — |
| Rapport Therapeutics, Inc. | RAPP | $25.06 | $1.20B | — | |
| Kardigan, Inc. | KARD | $12.85 | $1.20B | — | |
| Enovis Corporation | ENOV | $20.81 | $1.20B | — | |
| OPKO Health, Inc. | OPK | $1.60 | $1.19B | — | |
| Omeros Corporation | OMER | $16.26 | $1.18B | 13.3 | — |
| Syndax Pharmaceuticals, Inc. | SNDX | $13.15 | $1.17B | — | |
| Immatics N.V. | IMTX | $7.69 | $1.17B | — | |
| Knight Therapeutics Inc. | GUD.TO | CA$11.70 | CA$1.15B | 78.0 | — |
| Teladoc Health, Inc. | TDOC | $6.30 | $1.14B | — |
Kestra Medical Technologies, Ltd.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $1.63B
- P/E
- unprofitable
Sonida Senior Living, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.61B
- P/E
- unprofitable
Hemab Therapeutics Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.60B
- P/E
- unprofitable
Phibro Animal Health Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.59B
- P/E
- 16.2
- Dividend Yield
- 1.24%
uniQure N.V.
Healthcare / Biotechnology
- Market Cap
- $1.57B
- P/E
- unprofitable
Ultragenyx Pharmaceutical Inc.
Healthcare / Biotechnology
- Market Cap
- $1.57B
- P/E
- unprofitable
Structure Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $1.57B
- P/E
- unprofitable
Azenta, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $1.57B
- P/E
- unprofitable
COMPASS Pathways plc
Healthcare / Medical Care Facilities
- Market Cap
- $1.56B
- P/E
- unprofitable
First Tracks Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.53B
- P/E
- unprofitable
agilon health, inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.53B
- P/E
- unprofitable
Ascentage Pharma Group Internat
Healthcare / Biotechnology
- Market Cap
- $1.53B
- P/E
- unprofitable
Innoviva, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.51B
- P/E
- 4.9
Freenome, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.51B
- P/E
- unprofitable
Healthcare Services Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.49B
- P/E
- 12.7
Korsana Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.48B
- P/E
- unprofitable
Certara, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.46B
- P/E
- unprofitable
Pacira BioSciences, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.45B
- P/E
- 103.8
Inhibrx Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.45B
- P/E
- unprofitable
ORIC Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.44B
- P/E
- unprofitable
The Pennant Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.43B
- P/E
- 45.1
AnaptysBio, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.43B
- P/E
- unprofitable
CONMED Corporation
Healthcare / Medical Devices
- Market Cap
- $1.43B
- P/E
- 25.7
Ocular Therapeutix, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.42B
- P/E
- unprofitable
Tyra Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.42B
- P/E
- unprofitable
Eton Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.41B
- P/E
- 123.3
Nutex Health Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.35B
- P/E
- 7.8
Taysha Gene Therapies, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.34B
- P/E
- unprofitable
Damora Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.33B
- P/E
- unprofitable
Nanobiotix S.A.
Healthcare / Biotechnology
- Market Cap
- $1.32B
- P/E
- unprofitable
Nektar Therapeutics
Healthcare / Biotechnology
- Market Cap
- $1.31B
- P/E
- unprofitable
GH Research PLC
Healthcare / Biotechnology
- Market Cap
- $1.30B
- P/E
- unprofitable
U.S. Physical Therapy, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.29B
- P/E
- 479.3
- Dividend Yield
- 2.11%
LB Pharmaceuticals Inc
Healthcare / Biotechnology
- Market Cap
- $1.27B
Cronos Group Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.25B
- P/E
- 17.8
InnovAge Holding Corp.
Healthcare / Medical Care Facilities
- Market Cap
- $1.25B
- P/E
- unprofitable
Alpha Tau Medical Ltd.
Healthcare / Biotechnology
- Market Cap
- $1.25B
- P/E
- unprofitable
Silence Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $1.22B
- P/E
- unprofitable
GoodRx Holdings, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.22B
- P/E
- 71.4
Bicara Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $1.21B
- P/E
- unprofitable
Omada Health, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.20B
- P/E
- 81.9
Rapport Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.20B
- P/E
- unprofitable
Kardigan, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.20B
- P/E
- unprofitable
Enovis Corporation
Healthcare / Medical Devices
- Market Cap
- $1.20B
- P/E
- unprofitable
OPKO Health, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.19B
- P/E
- unprofitable
Omeros Corporation
Healthcare / Biotechnology
- Market Cap
- $1.18B
- P/E
- 13.3
Syndax Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.17B
- P/E
- unprofitable
Immatics N.V.
Healthcare / Biotechnology
- Market Cap
- $1.17B
- P/E
- unprofitable
Knight Therapeutics Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$1.15B
- P/E
- 78.0
Teladoc Health, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.14B
- P/E
- unprofitable
Showing 301–350 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.